These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 19054188)

  • 1. Omega-3 fatty acid supplementation effects on weight and appetite in patients with Alzheimer's disease: the omega-3 Alzheimer's disease study.
    Irving GF; Freund-Levi Y; Eriksdotter-Jönhagen M; Basun H; Brismar K; Hjorth E; Palmblad J; Vessby B; Vedin I; Wahlund LO; Cederholm T
    J Am Geriatr Soc; 2009 Jan; 57(1):11-7. PubMed ID: 19054188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
    Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
    Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study.
    Freund Levi Y; Vedin I; Cederholm T; Basun H; Faxén Irving G; Eriksdotter M; Hjorth E; Schultzberg M; Vessby B; Wahlund LO; Salem N; Palmblad J
    J Intern Med; 2014 Apr; 275(4):428-36. PubMed ID: 24410954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms.
    Freund-Levi Y; Basun H; Cederholm T; Faxén-Irving G; Garlind A; Grut M; Vedin I; Palmblad J; Wahlund LO; Eriksdotter-Jönhagen M
    Int J Geriatr Psychiatry; 2008 Feb; 23(2):161-9. PubMed ID: 17582225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study.
    Freund-Levi Y; Hjorth E; Lindberg C; Cederholm T; Faxen-Irving G; Vedin I; Palmblad J; Wahlund LO; Schultzberg M; Basun H; Eriksdotter Jönhagen M
    Dement Geriatr Cogn Disord; 2009; 27(5):481-90. PubMed ID: 19439966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study.
    Chiu CC; Su KP; Cheng TC; Liu HC; Chang CJ; Dewey ME; Stewart R; Huang SY
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1538-44. PubMed ID: 18573585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 fatty acid supplementation in patients with chronic epilepsy: a randomized trial.
    Yuen AW; Sander JW; Fluegel D; Patsalos PN; Bell GS; Johnson T; Koepp MJ
    Epilepsy Behav; 2005 Sep; 7(2):253-8. PubMed ID: 16006194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of omega-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo-controlled, double-blind trial.
    Hamazaki K; Itomura M; Huan M; Nishizawa H; Sawazaki S; Tanouchi M; Watanabe S; Hamazaki T; Terasawa K; Yazawa K
    Nutrition; 2005 Jun; 21(6):705-10. PubMed ID: 15925295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study.
    Tully AM; Roche HM; Doyle R; Fallon C; Bruce I; Lawlor B; Coakley D; Gibney MJ
    Br J Nutr; 2003 Apr; 89(4):483-9. PubMed ID: 12654166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of weight and fat-free mass with oral nutritional supplementation in patients with Alzheimer's disease at risk of malnutrition: a prospective randomized study.
    Lauque S; Arnaud-Battandier F; Gillette S; Plaze JM; Andrieu S; Cantet C; Vellas B
    J Am Geriatr Soc; 2004 Oct; 52(10):1702-7. PubMed ID: 15450048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma n-3 fatty acid response to an n-3 fatty acid supplement is modulated by apoE epsilon4 but not by the common PPAR-alpha L162V polymorphism in men.
    Plourde M; Vohl MC; Vandal M; Couture P; Lemieux S; Cunnane SC
    Br J Nutr; 2009 Oct; 102(8):1121-4. PubMed ID: 19828088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.
    Jatoi A; Rowland K; Loprinzi CL; Sloan JA; Dakhil SR; MacDonald N; Gagnon B; Novotny PJ; Mailliard JA; Bushey TI; Nair S; Christensen B;
    J Clin Oncol; 2004 Jun; 22(12):2469-76. PubMed ID: 15197210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratio.
    Burns T; Maciejewski SR; Hamilton WR; Zheng M; Mooss AN; Hilleman DE
    Pharmacotherapy; 2007 May; 27(5):633-8. PubMed ID: 17461697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating fatty acid profiles in response to three levels of dietary omega-3 fatty acid supplementation in horses.
    King SS; Abughazaleh AA; Webel SK; Jones KL
    J Anim Sci; 2008 May; 86(5):1114-23. PubMed ID: 18192545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-3 fatty acids in the gravid pig uterus as affected by maternal supplementation with omega-3 fatty acids.
    Brazle AE; Johnson BJ; Webel SK; Rathbun TJ; Davis DL
    J Anim Sci; 2009 Mar; 87(3):994-1002. PubMed ID: 18997072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of conjugated linoleic acid supplementation after weight loss on appetite and food intake in overweight subjects.
    Kamphuis MM; Lejeune MP; Saris WH; Westerterp-Plantenga MS
    Eur J Clin Nutr; 2003 Oct; 57(10):1268-74. PubMed ID: 14506488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study.
    Saifullah A; Watkins BA; Saha C; Li Y; Moe SM; Friedman AN
    Nephrol Dial Transplant; 2007 Dec; 22(12):3561-7. PubMed ID: 17623719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of prescription omega-3 fatty acids on body weight after 8 to 16 weeks of treatment for very high triglyceride levels.
    Bays HE; Maki KC; Doyle RT; Stein E
    Postgrad Med; 2009 Sep; 121(5):145-50. PubMed ID: 19820283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients.
    Geleijnse JM; Giltay EJ; Kromhout D
    Alzheimers Dement; 2012 Jul; 8(4):278-87. PubMed ID: 21967845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects on transthyretin in plasma and cerebrospinal fluid by DHA-rich n - 3 fatty acid supplementation in patients with Alzheimer's disease: the OmegAD study.
    Faxén-Irving G; Freund-Levi Y; Eriksdotter-Jönhagen M; Basun H; Hjorth E; Palmblad J; Vedin I; Cederholm T; Wahlund LO
    J Alzheimers Dis; 2013; 36(1):1-6. PubMed ID: 23563245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.